Emcure Pharmaceuticals gets EIR for Pune manufacturing facility

21 Apr 2025 Evaluate

Emcure Pharmaceuticals has received Establishment Inspection Report (EIR) for its manufacturing facility located at Pune. Further, United States Food & Drug Administration (USFDA) has classified the inspection of the said facility as ‘Voluntary Action Indicated’ (VAI).

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.  

Emcure Pharma Share Price

1406.60 -19.10 (-1.34%)
24-Dec-2025 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.90
Dr. Reddys Lab 1262.00
Cipla 1494.50
Zydus Lifesciences 917.25
Lupin 2106.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×